2-METHYL-6-(TRIFLUOROMETHOXY)-1H-INDOLE, 95.0%, 1g

5-Cyclopropyl-1,2,4-oxadiazole-3-carboxylic acid, 95%, 100mg

4-(CYANOMETHYLAMINO)BENZOIC ACID, 95.0%, 1g

tert-Butoxydiphenylchlorosilane (stabilized with CaCO3)>95.0%(GC)25mL

Glass vials with rolled rim Tall, 25 ml, Height, 50 mm, 200 Piece(s)

(1R,3S)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate compound with (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate, 98%, 10g

4-(tert-Butoxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid, 95.0%, 100mg

Ethyl 2-amino-4-bromo-3-methylbenzoate, 98%, 10g

N-(4-acetylphenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetamide, 98%, 10mg

Fmoc-2-amino-5-Methoxybenzoic acid, 5g

6,7-Dihydro-5H-[2]pyrindin-7-ylamine dihydrochloride, 98%, 250mg

4-Bromo-2-(difluoromethoxy)phenylisothiocyanate, 95.0%, 5g

1-Boc-6-Amino-2,3-dihydroindole, 95.0%, 100mg